QXO (QXO) had the highest return in December 2023 by a US stock with a market cap of $2B+, returning 364.9%.
| ASSET | MONTH | % RETURN |
|---|---|---|
QXO (QXO) | December 2023 | 364.95% |
Cytokinetics (CYTK) | December 2023 | 149% |
Sezzle Inc Common Stock (SEZL) | December 2023 | 105.41% |
Terawulf (WULF) | December 2023 | 101.68% |
Aurora Innovation (AUR) | December 2023 | 101.38% |
Marathon Digital (MARA) | December 2023 | 92.54% |
CleanSpark (CLSK) | December 2023 | 86.63% |
Edgewise Therapeutics (EWTX) | December 2023 | 81.73% |
Compass (COMP) | December 2023 | 71.69% |
Carvana (CVNA) | December 2023 | 70.66% |
Longboard Pharmaceuticals (LBPH) | December 2023 | 60.37% |
Compania de Minas Buenaventura SAA ADR (BVN) | December 2023 | 60.25% |
GeneDx (WGS) | December 2023 | 59.88% |
EchoStar (SATS) | December 2023 | 56.17% |
Rocket Companies (RKT) | December 2023 | 55.7% |
Twist Bioscience (TWST) | December 2023 | 54.74% |
Upstart Holdings (UPST) | December 2023 | 54.31% |
Sunrun (RUN) | December 2023 | 54.08% |
Century Aluminum (CENX) | December 2023 | 53.28% |
Viking Therapeutics (VKTX) | December 2023 | 50.08% |
Scholar Rock (SRRK) | December 2023 | 49.44% |
Tandem Diabetes Care (TNDM) | December 2023 | 48.42% |
Verona Pharma PLC ADR (VRNA) | December 2023 | 47.26% |
Dream Finders Homes (DFH) | December 2023 | 45.97% |
Recursion Pharmaceuticals (RXRX) | December 2023 | 45.86% |
